Edgestream Partners’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-108,725	Closed	-$2.34M	–	1097
2025 Q4	$2.34M	Sell	108,725 -62,072	-36%	-$1.31M	0.07%	492
2025 Q3	$3.29M	Buy	170,797 +87,818	+106%	+$1.57M	0.1%	389
2025 Q2	$1.42M	Buy	82,979 +74,427	+870%	+$3.18M	0.04%	589
2025 Q1	$546K	Buy	+8,552	New	+$900K	0.02%	687
2024 Q4	–	Sell	-18,459	Closed	-$2.31M	–	1075
2024 Q3	$2.31M	Buy	+18,459	New	+$2.55M	0.1%	360
2024 Q2	–	Sell	-4,841	Closed	-$627K	–	1025
2024 Q1	$627K	Buy	+4,841	New	+$593K	0.03%	603
2023 Q4	–	Sell	-3,648	Closed	-$442K	–	1053
2023 Q3	$442K	Buy	3,648 +905	+33%	+$102K	0.04%	619
2023 Q2	$314K	Buy	+2,743	New	+$354K	0.03%	623